UroGen Pharma (URGN) EBITDA (2018 - 2026)
UroGen Pharma's EBITDA was $211,000 in Q2 2026, compared with -$41.35 million a year earlier.
Powered by 
Analysis
UroGen Pharma (URGN) EBITDA (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, UroGen Pharma's EBITDA was -$66.28 million through Jun 30, 2026; for FY2025, it came in at -$124.56 million.
- In earlier years, EBITDA was -$96.45 million in FY2024, -$64.73 million in FY2023, -$78.12 million in FY2022 and -$91.46 million in FY2021.
- The Q2 2026 figure marks the highest quarterly EBITDA in data going back to Q1 2018.
- Per Business Quant data, URGN's EBITDA in the three quarters before Q2 2026 was -$20.16 million (Q1 2026), -$19.04 million (Q4 2025) and -$27.29 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.85 Bn | 1,106.43 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 618.85 Bn | 537.37 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 503.03 Bn | 476.14 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 368.52 Bn | 322.90 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 298.19 Bn | 262.18 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.33 Bn | 235.02 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 237.14 Bn | 192.53 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 191.35 Bn | 165.54 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 169.80 Bn | 116.45 Bn | 10.94 Bn | 5.89 Bn |
| 10 | UroGen Pharma | 1.80 Bn | 1.30 Bn | 65.88 Mn | -585,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -585,000.00 |
| Mar 31, 2026 | -18.19 Mn |
| Dec 31, 2025 | -18.94 Mn |
| Sep 30, 2025 | -27.68 Mn |
| Jun 30, 2025 | -40.95 Mn |
| Mar 31, 2025 | -36.44 Mn |
| Dec 31, 2024 | -27.60 Mn |
| Sep 30, 2024 | -18.04 Mn |
| Jun 30, 2024 | -25.52 Mn |
| Mar 31, 2024 | -26.58 Mn |
| Dec 31, 2023 | -14.39 Mn |
| Sep 30, 2023 | -13.08 Mn |
| Jun 30, 2023 | -14.83 Mn |
| Mar 31, 2023 | -21.42 Mn |
| Dec 31, 2022 | -19.38 Mn |
| Sep 30, 2022 | -17.21 Mn |
| Jun 30, 2022 | -18.39 Mn |
| Mar 31, 2022 | -21.46 Mn |
| Dec 31, 2021 | -19.70 Mn |
| Sep 30, 2021 | -23.24 Mn |
API Access
UroGen Pharma EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=URGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "URGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=URGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();